Literature DB >> 15896803

Influence of ions, hydration, and the transcriptional inhibitor P4N on the conformations of the Sp1 binding site.

Julie A Dohm1, Ming-Hua Hsu, Jih-Ru Hwu, Ru Chih C Huang, Evangelos N Moudrianakis, Eaton E Lattman, Apostolos G Gittis.   

Abstract

Three crystal structures containing the entire Sp1 consensus sequence d(GGGGCGGGG) with two or three additional base-pairs on either the 5' or 3' ends and overhangs have been determined. Despite the different lengths of DNA in the pseudo-dodecamers and pseudo-tridecamer, all three structures form A-DNA duplexes that share a common set of crystal contacts, including a T*(G.C) base triplet and a 5'-overhang that flips out and away from the helical axes to form a Hoogsteen base-pair with the 3'-overhang of a symmetry mate. The global conformations of the three structures differ, however, in the widths of their respective major grooves, the lengths of the molecules, and the extent of crystal packing. The structures were determined from crystals grown in an unusual precipitant for A-DNA, polyethylene glycol (PEG) 400, in combination with polyamines or ions; cobalt hexamine for the pseudo-tridecamer, and spermidine for the pseudo-dodecamers. As the Sp1 binding site is a target for antiviral and anticancer drugs, pseudo-dodecamer crystals were soaked with one such antiviral and anticancer compound, P4N. Although P4N was not visualized unambiguously in the electron density maps, the effect of the drug is evident from significant differences in the lattice constants, crystal packing, and overall conformation of the structure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15896803     DOI: 10.1016/j.jmb.2005.04.001

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  5 in total

1.  In vivo amelioration of endogenous antitumor autoantibodies via low-dose P4N through the LTA4H/activin A/BAFF pathway.

Authors:  Yu-Ling Lin; Nu-Man Tsai; Cheng-Hao Hsieh; Shu-Yi Ho; Jung Chang; Hsin-Yi Wu; Ming-Hua Hsu; Chia-Ching Chang; Kuang-Wen Liao; Tiffany L B Jackson; David E Mold; Ru Chih C Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-17       Impact factor: 11.205

2.  Significant biological role of sp1 transactivation in multiple myeloma.

Authors:  Mariateresa Fulciniti; Samir Amin; Puru Nanjappa; Scott Rodig; Rao Prabhala; Cheng Li; Stephane Minvielle; Yu-Tzu Tai; Pierfrancesco Tassone; Herve Avet-Loiseau; Teru Hideshima; Kenneth C Anderson; Nikhil C Munshi
Journal:  Clin Cancer Res       Date:  2011-08-19       Impact factor: 12.531

Review 3.  Structure-based DNA-targeting strategies with small molecule ligands for drug discovery.

Authors:  Jia Sheng; Jianhua Gan; Zhen Huang
Journal:  Med Res Rev       Date:  2013-04-30       Impact factor: 12.944

4.  A microfluidic-FCS platform for investigation on the dissociation of Sp1-DNA complex by doxorubicin.

Authors:  Hsin-Chih Yeh; Christopher M Puleo; Teck Chuan Lim; Yi-Ping Ho; Paul E Giza; Ru Chih C Huang; Tza-Huei Wang
Journal:  Nucleic Acids Res       Date:  2006-11-15       Impact factor: 16.971

Review 5.  Creosote bush lignans for human disease treatment and prevention: Perspectives on combination therapy.

Authors:  John Gnabre; Robert Bates; Ru Chih Huang
Journal:  J Tradit Complement Med       Date:  2015-03-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.